User talk:Michael.Yen

From EyeWiki

Assigned editor status

 Article statusDate reviewed
Apraxia of Eyelid OpeningUp to Date2 August 2024
Asian Blepharoplasty (Double Eyelid Procedure)Up to Date1 June 2024
BlepharitisUp to Date2 September 2024
BlepharospasmUp to Date12 October 2024
Conjunctival Reactive Lymphoid HyperplasiaUp to Date15 July 2024
CryptophthalmosUp to Date17 September 2024
DacryocystorhinostomyUp to Date2 September 2024
Demodex InfestationUp to Date21 October 2024
DermatochalasisUp to Date13 October 2024
Dermoid CystUp to Date25 October 2024
EpiblepharonUp to Date25 October 2024
Epicanthal FoldsUp to Date25 October 2024
Eye in NumbersUp to Date2 July 2024
Facial ReanimationUp to Date30 May 2024
Firearm Ocular InjuryUp to Date2 October 2024
Infraorbital Rim/Tear Trough Implants in Context of Thyroid Eye Disease/Prominent GlobeUp to Date16 June 2024
Invasive Fungal Infections of the Orbit and SinusesUp to Date2 October 2024
Lacrimal Gland AbscessUp to Date1 August 2024
Malar / Midface DescentUp to Date22 August 2024
Nerve Supply of the EyelidsUp to Date25 October 2024
Ocular Manifestations of Ectodermal DysplasiaUp to Date23 October 2024
OncocytomaUp to Date2 September 2024
Ophthalmic Features of Systemic Capillary Leak SyndromeUp to Date24 June 2024
Orbital Applications of Microautologous Fat TransplantationUpdate Pending
Orbital Cavernous Venous Malformation (Cavernous Hemangioma)Up to Date12 October 2024
Orbital CellulitisUp to Date25 October 2024
Periorbital Necrotizing FasciitisUp to Date13 October 2024
Photo-OculodyniaUp to Date2 July 2024
PilomatrixomaUp to Date1 November 2024
Preseptal CellulitisUp to Date13 October 2024
Prostaglandin Associated PeriorbitopathyUp to Date13 October 2024
Schwartz-Jampel SyndromeUp to Date15 July 2024
Secondary Acquired Nasolacrimal Duct ObstructionUp to Date12 October 2024
Superior Ophthalmic Vein Cannulation for Treatment of Cavernous Sinus-Dural FistulasUp to Date21 October 2024
The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.